Gilead Sciences, Inc. 5.65% 01-DEC-2041Gilead Sciences, Inc. 5.65% 01-DEC-2041Gilead Sciences, Inc. 5.65% 01-DEC-2041

Gilead Sciences, Inc. 5.65% 01-DEC-2041

No trades
See on Supercharts

GILD.GO analysis



Key facts


Issue date
Dec 13, 2011
Maturity date
Dec 1, 2041
Outstanding amount
‪1.00 B‬USD
Face value
1,000.00USD
Minimum denomination
2,000.00USD
Coupon
5.65% (Fixed)
Yield to maturity
5.39%
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.